Barcelona-based photonics research centre specializing in quantum technologies, biophotonics, and graphene, with 120 H2020 projects and EUR 78M in EU funding.
ICFO is a world-class photonics research centre near Barcelona that develops light-based technologies spanning quantum information, biomedical imaging, graphene applications, and nanophotonics. They design and build optical sensors, quantum communication systems, and advanced spectroscopy tools with direct applications in healthcare diagnostics, secure communications, and energy harvesting. The institute also runs a major doctoral training programme (ICFOstepstone) that feeds trained photonics researchers into European industry and academia. Their work bridges fundamental physics — atom-light interactions, quantum simulation, optomechanics — with applied devices like portable biosensors and wearable health monitors.
Dozens of projects spanning quantum simulation (QUIC, TOP-DOL), quantum optomechanics (QnanoMECA, SEQOO), quantum magnetometry (QUTEMAG), and quantum communication (recent projects on quantum cryptography, QKD, quantum networks).
Projects like LUCA (laser-ultrasound thyroid analyzer), BitMap (brain injury monitoring), GLAM (laser biosensor), RAIS (sepsis detection), and CYTO-WATER demonstrate sustained work applying photonics to medical diagnostics and biosensing.
Active participant in GrapheneCore1 (EUR 2M), plus projects like NANOSOLAR (quantum-dot/graphene photovoltaics), GRAPHEALTH (graphene wearable sensors), and TOP-DOL (graphene-related topological physics).
Projects including LightNet (coherent light in photosynthetic networks, EUR 2.86M), LANTERN (light-atom interactions in nanophotonic structures), NanoLight, and FoQAL focus on controlling light at the nanoscale.
Recent keyword surge in quantum cryptography, quantum key distribution, quantum networks, and certification — indicating a strategic pivot toward secure quantum communication infrastructure.
ICFOstepstone PhD programme (EUR 1.57M) plus 25 MSCA individual fellowships demonstrate ICFO as a major training hub for early-career photonics researchers across Europe.
In the early H2020 period (2015–2018), ICFO focused heavily on fundamental physics: graphene, nanophotonics, quantum simulation, and nonlinear photonics, with a strong pipeline of individual MSCA fellowships in these areas. From 2019 onward, the emphasis shifted markedly toward applied quantum technologies — quantum communication, quantum cryptography, quantum key distribution, and quantum network certification became dominant themes. Biophotonics also intensified in the later period, with more projects targeting specific medical applications like brain injury monitoring and biomedical optics, while graphene research remained a constant thread throughout.
ICFO is pivoting from fundamental photonics research toward deployable quantum communication infrastructure and medical photonics devices — expect growing interest in quantum security pilots and clinical biophotonics validation.
ICFO is a dominant consortium leader, coordinating 68 of 120 projects (57%), which is exceptionally high for a research centre — most of these are ERC grants and MSCA fellowships where they are the sole or lead beneficiary. When they do join consortia as partners (50 projects), they work with a remarkably broad network of 656 unique partners across 36 countries, suggesting they are a sought-after specialist contributor rather than a repeat-partner loyalist. Their comfort leading projects of all sizes — from EUR 150K proof-of-concept grants to EUR 2.8M ERC consolidators — makes them a flexible partner who can anchor a consortium or fill a precise technical niche.
ICFO has collaborated with 656 unique partners across 36 countries, making them one of the most extensively networked photonics centres in Europe. Their geographic reach spans the full EU and associated countries, with no strong regional bias beyond the expected Western European concentration.
ICFO occupies a rare position as a research centre that excels equally in fundamental quantum physics and applied photonic devices — most institutes lean one way or the other. Their combination of deep quantum optics expertise, graphene materials capability, and biomedical photonics application know-how means they can take a technology from first principles through to a working prototype. With 68 coordinated H2020 projects and EUR 78M in funding, they have proven grant-winning capability that de-risks any consortium they join.
